Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that, after entering into a license agreement with the U.S.

Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never ...

A new HIV vaccine has generated powerful broadly neutralizing antibodies in animal studies and has now entered human trials, ...

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

mRNA technology is enabling an entirely new HIV vaccine strategy that, for the first time, successfully primes the immune system toward broadly neutralizing antibodies in humans. The TB vaccine ...